| Serial Number | 97382404 |
| Word Mark | THE GENE TO ANTIBODY COMPANY |
| Filing Date | Tuesday, April 26, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 2, 2024 |
| Registration Number | 7264779 |
| Registration Date | Tuesday, January 2, 2024 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Biomanufacturing for others, namely, manufacturing of antibodies, proteins, and plasmids using biological organisms in the manufacturing process |
| Disclaimer with Predetermined Text | "COMPANY" |
| Goods and Services | Biotechnology research; Development of new technology for others in the field of biotechnology and pharmaceuticals; Laboratory research services relating to pharmaceuticals; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing information on the subject of scientific research in the field of biochemistry and biotechnology |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 2, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | Sunday, November 1, 2020 |
| First Use In Commerce Date | Sunday, November 1, 2020 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 2, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, November 1, 2020 |
| First Use In Commerce Date | Sunday, November 1, 2020 |
| Party Name | Genovac Antibody Discovery LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Fargo, ND 58102 |
| Party Name | Genovac Antibody Discovery LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Fargo, ND 58102 |
| Event Date | Event Description |
| Tuesday, January 2, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, January 2, 2024 | REGISTERED-SUPPLEMENTAL REGISTER |
| Wednesday, April 26, 2023 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| Wednesday, April 26, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, April 26, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 26, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 26, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, March 15, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, February 21, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 21, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 21, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, February 13, 2023 | ASSIGNED TO EXAMINER |
| Monday, May 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 29, 2022 | NEW APPLICATION ENTERED |